Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novaquest Pharma Opportunities Fund , L.P. Insider Profile
4 Followers
Novaquest Pharma Opportunities Fund , L.P., Ten Percent Owner at Revance Therapeutics, holds 3.10M shares in Revance Therapeutics (Ticker: RVNC).
Novaquest Pharma Opportunities Fund , L.P. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Novaquest Pharma Opportunities Fund , L.P. does not currently own shares as a corporate insider.
A breakdown of Novaquest Pharma Opportunities Fund , L.P.'s holdings
Insider Roles
Ten Percent Owner
Roles that Novaquest Pharma Opportunities Fund , L.P. holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Novaquest Pharma Opportunities Fund , L.P.
Novaquest Pharma Opportunities Fund , L.P.'s Trading History
List of latest transactions for each holding click on a transaction to see Novaquest Pharma Opportunities Fund , L.P.'s performance on stock
You May Also Like
Novaquest Pharma Opportunities Fund , L.P. insider profile FAQ
What is the percentage of profitable transactions made by Novaquest Pharma Opportunities Fund , L.P.?
The percentage of profitable transactions made by Novaquest Pharma Opportunities Fund , L.P. is ―.
What is the average return per transaction made by Novaquest Pharma Opportunities Fund , L.P.?
The average return per transaction made by Novaquest Pharma Opportunities Fund , L.P. is ―.
What stocks does Novaquest Pharma Opportunities Fund , L.P. hold?
Novaquest Pharma Opportunities Fund , L.P. holds: RVNC stocks.
What was Novaquest Pharma Opportunities Fund , L.P.’s latest transaction?
Novaquest Pharma Opportunities Fund , L.P. latest transaction was an Uninformative Buy of ―.
What was Novaquest Pharma Opportunities Fund , L.P.'s most profitable transaction?
Novaquest Pharma Opportunities Fund , L.P.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Novaquest Pharma Opportunities Fund , L.P.'s role in Revance Therapeutics?
Novaquest Pharma Opportunities Fund , L.P.'s role in Revance Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.